4//SEC Filing
Chaturvedi Vipin 4
Accession 0001824293-23-000102
CIK 0001824293other
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 6:29 PM ET
Size
5.4 KB
Accession
0001824293-23-000102
Insider Transaction Report
Form 4
Chaturvedi Vipin
Chief Scientific Officer
Transactions
- Award
Common Stock
2023-04-21+172,189→ 172,189 total
Footnotes (1)
- [F1]Received in exchange for 4,600,000 shares of common stock of GRI Bio, Inc. ("GRI"), pursuant to the Agreement and Plan of Merger, dated December 13, 2022, by and among Vallon Pharmaceuticals, Inc. (the "Company"), Vallon Merger Sub, Inc. and GRI Bio, Inc. (the "Merger"). Per the terms of the Merger, each share of GRI common stock was converted into the right to receive 0.0374 shares of the Company's common stock. In connection with the Merger, the Company effected a reverse stock split of the Company's common stock at a ratio of 1-for-30 (the "Reverse Split"). Unless noted otherwise, all references to share amounts in this Form 4 reflect the Reverse Split.
Documents
Issuer
GRI BIO, Inc.
CIK 0001824293
Entity typeother
Related Parties
1- filerCIK 0001971423
Filing Metadata
- Form type
- 4
- Filed
- Apr 23, 8:00 PM ET
- Accepted
- Apr 24, 6:29 PM ET
- Size
- 5.4 KB